The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment
Linjie Dong, Lin Yan, Yi Li, Mei Li, Weihua Feng, Xiaoqiong Li, Jiaxi Yue, Erdi Zhang, Yao Luo, Yangjuan Bai · 2024
Read The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment by Linjie Dong, Lin Yan, Yi Li, Mei Li, Weihua Feng, Xiaoqiong Li, Jiaxi Yue, Erdi Zhang, Yao Luo, Yangjuan Bai (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11625799.txt.
Description
Linjie Dong and nine co-authors tracked B cells after treatment with rituximab in patients who did not have lymphoma, in a 2024 study. The drug wipes out B cells and is used for immune diseases and after kidney transplants. How fast B cells return varies by patient, and no shared rule sets how often to check.
The study followed 488 patients in four groups, from a nerve disease to a skin disease, a kidney disease, and transplant care, over seven years. Most patients showed high B cell levels again after twenty-four weeks, but a small share began regrowth within four weeks. A subset study mapped B cell types in one disease group. The authors say steady checks help time personal treatment.
Catalog record
| CREATOR | Linjie Dong, Lin Yan, Yi Li, Mei Li, Weihua Feng, Xiaoqiong Li, Jiaxi Yue, Erdi Zhang, Yao Luo, Yangjuan Bai |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |